Patent intelligence · US
US 11771680
Pyrrole compounds
Pyrrole compounds
Patent details — US 11771680
- Jurisdiction
- US
- Status
- granted
- Grant date
- Oct 3, 2023
- Expiration
- Sep 28, 2043
- Applicant
- Aligos Therapeutics, Inc.
- Claims
- 19
- CPC classes
- A61K, A61K31/40, A61K31/4025, A61K31/4192
Quick answer
US 11771680 (Pyrrole compounds) is held by Aligos Therapeutics, Inc.. Status: granted. Granted Oct 3, 2023. Expires Sep 28, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Aligos Therapeutics, Inc.
- Grant date
- Expiration
- Claims
- 19
- CPC classes
- A61K, A61K31/40, A61K31/4025, A61K31/4192
More from Aligos Therapeutics, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12384779
Bicyclic compounds
granted -
US 12252481
Anti-viral compounds
granted -
US 12180192
Modulators of THR-β and methods of use thereof
granted -
US 12129469
Modified short interfering nucleic acid (siNA) molecules and uses thereof
granted -
US 12065428
Anti-viral compounds
granted -
US 12018015
Methods and compositions for targeting PD-L1
granted -
US 11957683
Bicyclic compounds
granted -
US 11952374
Bicyclic compounds
granted
Related coverage
Frequently asked questions
What is US patent 11771680?
US 11771680 (Pyrrole compounds) is held by Aligos Therapeutics, Inc.. Status: granted. Granted Oct 3, 2023. Expires Sep 28, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11771680?
Aligos Therapeutics, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 32 pharmaceutical patents for this assignee.
When does US 11771680 expire?
Our index shows an expiration date of Sep 28, 2043 (17 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.